JAMA Oncol 2018 Nov 1
Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer.
Related Questions
New comment by Medical Oncologist at Stanford School of Medicine ( December 30, 2021)
Has recent data from the COXEN (S1314) trial and VESPER05 trial changed your practice?
Are you giving up to 6 cycles of ddMVAC given higher pCR rates, PFS, and OS in the neoa...